IBC Creates Subsidiary – GreenLiT Pure Lithium, Inc. – to Meet Booming Lithium Demand using IBC’s Proprietary Direct Lithium to Product™ (DLP™) Process
AMERICAN FORK, Utah, Jan. 25, 2024 /PRNewswire/ — GreenLiT Pure Lithium, Inc. (GreenLiT™), a wholly-owned subsidiary of IBC Advanced Technologies, Inc. (IBC), will commercialize IBC’s proprietary Direct Lithium to Product™ (DLP™) process, which provides a rapid, direct route to pro
The Scleroderma Research Foundation Appoints Dr. Gregory Gordon as Chief Medical Officer
Dr. Gordon will have oversight over the SRF’s global clinical trial program CONQUEST and will contribute to the research program across the SRF portfolio SAN FRANCISCO, Jan. 25, 2024 /PRNewswire/ — The Scleroderma Research Foundation (SRF)— the nation’s largest non-profit funder
Horizons ETFs Opens the Market
TORONTO, Jan. 25, 2024 /PRNewswire/ – Stephanie Wolfe, Executive Vice President and Head of Marketing at Horizons ETFs Management (Canada) Inc., along with the Horizons ETFs team plus a group of Personal Finance Educators, joined Graham Mackenzie, Managing Director, Exchange Traded Products, T
Alyssa’s Law in Action: Unveiling the Impacts on Texas School Safety
The state’s most used panic button provider, CENTEGIX®, releases a comprehensive report on how its wearable technology is making Texas schools safer every day. AUSTIN, Texas, Jan. 25, 2024 /PRNewswire/ — CENTEGIX®, the leader in incident response solutions, released today its report on
Resolutions at the Extraordinary General Meeting in Beyond Frames Entertainment AB (publ)
STOCKHOLM, Jan. 25, 2024 /PRNewswire/ — At the extraordinary general meeting of Beyond Frames Entertainment AB (publ) on January 24, 2024, in the company’s offices at Bondegatan 21 in Stockholm, the following main decisions were made. For detailed information about the decisions, refer
Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize
JERUSALEM, Jan. 25, 2024 /PRNewswire/ — Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I) biological products, congratulates the Company’s co-lead scientific research collaborator Professor Dr. Dirk
EY Entrepreneurs Access Network Welcomes its Fourth Cohort of Transformative Entrepreneurs
36 entrepreneurs from across the nation selected for EY US’s 12-month business accelerator to support scaling businesses NEW YORK, Jan. 25, 2024 /PRNewswire/ — Ernst & Young LLP (EY US) today announced that 36 Black and Hispanic/Latino entrepreneurs from seven industry segments wer
BEDGEAR Unveils ‘The Future is Now’ Theme Alongside Cutting-Edge Product Innovations at the 2024 Las Vegas Market
FARMINGDALE, N.Y., Jan. 25, 2024 /PRNewswire/ — BEDGEAR®, renowned in the sleep industry for pushing boundaries to offer innovative sleep solutions for humans who aspire to wake ready. The brand is proud to announce its B-1100 showroom theme for Las Vegas Winter Market 2024: “The Future
Sleepopolis Announces Launch of Podcast Sleep Talking with Dr. Shelby
The launch supports their ever-growing mission to help people get incredible sleep RALEIGH, N.C., Jan. 25, 2024 /PRNewswire/ — Sleepopolis, one of the largest sleep resources delivering best-in-class sleep news, mattress and bedding reviews and sleep health content, has announced the launch o
Top-Performing Companies Tie Tech Spend to Strategic Priorities
They Plan and Spend Differently, and Address Tech in the Boardroom, According to L.E.K. Consulting Study BOSTON, Jan. 25, 2024 /PRNewswire/ — Companies are spending heavily on digital technologies but the top performers are doing it differently – they are spending on their most critical bus
